These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9749439)

  • 1. Methodological advances and plans for improving regulatory success for confirmatory studies.
    Koch GG; Davis SM; Anderson RL
    Stat Med; 1998 Aug 15-30; 17(15-16):1675-90. PubMed ID: 9749439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of interim analyses in drug development.
    Facey KM; Lewis JA
    Stat Med; 1998 Aug 15-30; 17(15-16):1801-9; discussion 1811-2. PubMed ID: 9749448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seeking harmony: estimands and sensitivity analyses for confirmatory clinical trials.
    Mehrotra DV; Hemmings RJ; Russek-Cohen E;
    Clin Trials; 2016 Aug; 13(4):456-8. PubMed ID: 26908545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory perspectives on data safety monitoring boards: protecting the integrity of data.
    Hemmings R; Day S
    Drug Saf; 2004; 27(1):1-6. PubMed ID: 14720083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug Administration.
    Brannath W; Burger HU; Glimm E; Stallard N; Vandemeulebroecke M; Wassmer G
    J Biopharm Stat; 2010 Nov; 20(6):1125-31. PubMed ID: 21058108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methodological recommendations of the Regulatory Agencies].
    Torres F; Calvo G; Pontes C
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():72-6. PubMed ID: 16464431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-tailed tests and a statistical significance at 0.05: what do they mean?
    Campbell M
    Midwifery; 2004 Jun; 20(2):142-3. PubMed ID: 15177857
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized clinical trials in medical rehabilitation research.
    Tate DG; Findley T; Dijkers M; Nobunaga AI; Karunas RB
    Am J Phys Med Rehabil; 1999; 78(5):486-99. PubMed ID: 10493460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity in research.
    Roberts P; Priest H
    Nurs Stand; 2006 Jul 12-18; 20(44):41-5. PubMed ID: 16872117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological considerations with secondary analyses.
    Pollack CD
    Outcomes Manag Nurs Pract; 1999; 3(4):147-52. PubMed ID: 10876539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Spreadsheets for Research Data Collection and Preparation: A Primer.
    Juluru K; Eng J
    Acad Radiol; 2015 Dec; 22(12):1592-9. PubMed ID: 26454810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A framework establishing clear decision criteria for the assessment of drug efficacy.
    Huster WJ; Enas GG
    Stat Med; 1998 Aug 15-30; 17(15-16):1829-38. PubMed ID: 9749450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Missing data: warrant for search and capture].
    Torres F; Pontes C
    Med Clin (Barc); 2013 Oct; 141(7):297-9. PubMed ID: 23706686
    [No Abstract]   [Full Text] [Related]  

  • 14. Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop.
    Khin NA; Francis G; Mulinde J; Grandinetti C; Skeete R; Yu B; Ayalew K; Cho SJ; Fisher A; Kleppinger C; Ayala R; Bonapace C; Dasgupta A; Kronstein PD; Vinter S
    Clin Pharmacol Ther; 2020 Nov; 108(5):949-963. PubMed ID: 31958142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some controversies in planning and analysing multi-centre trials.
    Senn S
    Stat Med; 1998 Aug 15-30; 17(15-16):1753-65; discussion 1799-800. PubMed ID: 9749445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
    Tuffs A
    BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
    [No Abstract]   [Full Text] [Related]  

  • 18. Research guidelines for the Delphi survey technique.
    Hasson F; Keeney S; McKenna H
    J Adv Nurs; 2000 Oct; 32(4):1008-15. PubMed ID: 11095242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives.
    Liu Q; Chi GY
    J Biopharm Stat; 2010 Nov; 20(6):1178-219. PubMed ID: 21058114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IPEG guideline on statistical design and analysis for pharmacodynamic trials. International Pharmaco-EEG Group.
    Ferber G; Abt K; Fichte K; Luthringer R
    Neuropsychobiology; 1999; 39(2):92-100. PubMed ID: 10072666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.